Novavax

Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September
Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today?
Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today?
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Trending Today
Novavax, Zscaler, Digital Brands Group, Asana, Tesla: Why These 5 Stocks Are Drawing Investor Attention Today

Novavax Recent News

Barron's Latest Picks And Pans: COVID Booster Shot Plays, Defense M&As, Coty, Hologic, And More
This weekend's Barron's cover story offers a look at the 100 must sustainable companies. Other featured articles discuss the changing vaccine industry, the history of electric vehicles and consolidation in the defense sector.
Investors Eye Vaccine Results From JNJ, Novavax Amid Broader Market Uncertainty
The last day of a volatile and heavily traded stock market week opens this morning with investors apparently feeling uneasy given the state of certain speculative trades that have been in the spotlight for days.
Fintech Focus For September 10, 2020
Benzinga's Bulls And Bears Of The Week: Apple, Salesforce, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. This past week's bullish calls included the iPhone maker and other tech leaders. The leading EV maker and a top biotech were among the bearish calls.
Benzinga's Bulls And Bears Of The Week: Apple, Ford, Merck, Uber And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. This week's bullish calls included pharmaceutical and ride-share leaders. The e-commerce colossus and the iPhone maker were among the week's bearish calls.
Benzinga's Bulls & Bears Of The Week: Altria, DowDupont, Oracle, Roku And More
Novavax CEO To Jim Cramer: 'We Are In For An Exciting Year'
Earnings Expectations For The Week Of March 10: The Season Winds Down
Market Wrap For December 16: Dow Posts Triple Point Gain Ahead of Fed Meeting
Wedbush Initiates Coverage Of Novavax With Outperform Rating And $6 Price Target
Novavax Awarded BARDA Contract, Increasing Target to $4
Piper Jaffray Raises PT On Novavax To $4
How Hysteria Kills The Market (NVAX)